MP Healthcare Venture Management
Home About Us Portfolio News Contact
HomeAbout UsPortfolioNewsContact
MP Healthcare Venture Management
Bristol-Myers Squibb Enters into Agreement that Provides an Exclusive Option to Acquire F-star Alpha Ltd. and its Novel HER2-Targeted Therapy.
Brennan CaruthersOctober 28, 2014
Facebook0 Twitter LinkedIn0 Reddit 0 Likes
Previous

F-star Announces the Formation of Second Asset-Centric Vehicle, F-star Beta Ltd.

Brennan CaruthersNovember 4, 2014
Next

Thrasos Announces Successful Formal Interim Analysis and Clinical Update.

Brennan CaruthersSeptember 16, 2014

© 2010-2019 MP Healthcare Venture Management, Inc.
All Rights Reserved.

Privacy Policy | Terms of Use

About UsPortfolioNews Contact